文献速递衰弱、肌少症与跌倒

肌少症筛查工具诊断准确性的系统综述与荟萃分析

The accuracy of screening instruments for sarcopenia: a diagnostic systematic review and meta-analysis.
PubMed 文献 · Age Ageing · 2023-01-01

该系统综述评估了肌少症筛查工具的诊断准确性,共纳入42项研究、5种筛查工具。SARC-F改良版、SARC-F和Ishii评分特异度均≥85%;MSRA、Ishii评分和U-TEST敏感度均≥75%。MSRA和Ishii评分早期筛查敏感度优异,SARC-F改良版和Ishii评分诊断特异度更优。

要点

  • SARC-F改良版特异度92%,SARC-F为87%,Ishii评分为85%。
  • MSRA敏感度82%,Ishii评分79%,U-TEST为76%。
  • Ishii评分阴性似然比0.25为所有量表最佳。

核心结论

  • MSRA和Ishii评分在肌少症早期筛查中敏感度优异。
  • SARC-F改良版和Ishii评分在肌少症诊断中特异度更优。

研究设计与样本

  • 系统综述与荟萃分析,检索并筛选了7120条标题和摘要。
  • 最终纳入42项研究,涉及5种肌少症筛查工具。
  • 使用COSMIN清单评估测量属性,QUADAS-2工具评估偏倚风险。
  • 总体研究质量经QUADAS-2评估为中等至良好。

主要发现

  • SARC-F改良版特异度为92%(95%CI:63-99%)。
  • SARC-F特异度为87%(95%CI:82-90%)。
  • Ishii评分特异度为85%(95%CI:77-90%)。
  • MSRA敏感度为82%(95%CI:69-90%)。
  • Ishii评分敏感度为79%(95%CI:62-89%),U-TEST敏感度为76%。

关键数值与推荐

  • Ishii评分和SARC-F改良版的正似然比高于5.0。
  • Ishii评分的阴性似然比为0.25,为所有量表最佳。
  • 三种工具特异度≥85%:SARC-F改良版、SARC-F和Ishii评分。
  • 三种工具敏感度≥75%:MSRA、Ishii评分和U-TEST。

临床怎么用

  • 早期筛查可优先选用MSRA或Ishii评分,因其敏感度较高。
  • 需提高诊断特异性时,可选用SARC-F改良版或Ishii评分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This review aimed to summarise the diagnostic accuracy of screening tools for sarcopenia. METHODS: We conducted a systematic review along with a critical appraisal of published studies on screening tools for sarcopenia. We assessed the measurement properties of screening instruments using the consensus-based standards for selecting health measurement instruments (COSMIN) checklist. We evaluated the risk bias of the included studies using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. The diagnostic test accuracy of instruments for sarcopenia was reported using sensitivity, specificity, positive likelihood ratio (PLR) and negative likelihood ratio (NLR). RESULTS: We screened 7,120 titles and abstracts; 42 studies including five screening tools for sarcopenia were included. The overall study quality assessed by the QUADAS-2 tool was moderate to good. Of the five screening tools, three instruments had specificities ≥85%: 92% [95% confidence interval (CI): 63-99%] for the SARC-F modified version, 87% (95% CI: 82-90%) for the SARC-F and 85% (95% CI: 77-90%) for the Ishii score. Three tools had sensitivity ≥75%, namely, MSRA 82% (95% CI: 69-90%), Ishii score 79% (95% CI: 62-89%) and U-TEST 76%. PLR higher than 5.0 were present for the Ishii score and SARC-F modified versions; the Ishii score also had the best NLR of 0.25 of all scales. CONCLUSION: The MSRA and Ishii score had excellent sensitivity for sarcopenia screening at an early stage; SARC-F modified versions and Ishii score had superior specificity for sarcopenia diagnosis.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Huang L, Shu X, Ge N, et al. The accuracy of screening instruments for sarcopenia: a diagnostic systematic review and meta-analysis. Age Ageing. 2023. PMID: 37596923. doi:10.1093/ageing/afad152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。